logo
welcome
Associated Press News

Associated Press News

EU Commission fines Teva $500 million for trying to stop rival's multiple sclerosis drug

Associated Press News
Summary
Nutrition label

82% Informative

European Commission says it has fined Israeli generic drugmaker Teva more than 460 million euros ( $500 million ) The pharmaceutical firm “misused the patent system to artificially extend patent protection” for its blockbuster MS drug Copaxone .

To do that, Teva conducted a “disparagement campaign” against Synthon , the only other company with an authorized drug in Europe containing glatiramer acetate.

VR Score

87

Informative language

89

Neutral language

48

Article tone

formal

Language

English

Language complexity

70

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

Source diversity

1

Affiliate links

no affiliate links